Erik S.G. Stroes

Overview

Best Publications

• 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular riskThe Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)

  François Mach;Colin Baigent;Alberico L Catapano;Konstantinos C Koskinas

  7143
  Citations

• Transfer of Intestinal Microbiota From Lean Donors Increases Insulin Sensitivity in Individuals With Metabolic Syndrome

  Anne Vrieze;Els Van Nood;Frits Holleman;Jarkko Salojarvi

  3367
  Citations

• Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

  Borge G. Nordestgaard;M. John Chapman;Steve E. Humphries;Henry N. Ginsberg

  3072
  Citations

• Efficacy and Safety of Alirocumab in Reducing Lipids and Cardiovascular Events

  Jennifer G. Robinson;Michel Farnier;Michel Krempf;Jean Bergeron

  2446
  Citations

• Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia

  John J.P. Kastelein;Fatima Akdim;Erik S.G. Stroes;Aeilko H. Zwinderman

  1739
  Citations

• Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

  Erik S. Stroes;Paul D. Thompson;Alberto Corsini;Georgirene D. Vladutiu

  1484
  Citations

• Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society

  Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  1188
  Citations

• Improvement of Insulin Sensitivity after Lean Donor Feces in Metabolic Syndrome Is Driven by Baseline Intestinal Microbiota Composition

  Ruud S. Kootte;Evgeni Levin;Jarkko Salojärvi;Loek P. Smits

  1017
  Citations

• Familial Hypercholesterolaemia in Children and Adolescents: Gaining Decades of Life by Optimizing Detection and Treatment

  Albert Wiegman;Samuel S. Gidding;Gerald F Watts;M John Chapman

  902
  Citations

• Tetrahydrobiopterin restores endothelial function in hypercholesterolemia.

  E Stroes;J Kastelein;F Cosentino;W Erkelens

  857
  Citations

• Lipoprotein(a) Reduction in Persons with Cardiovascular Disease.

  Tsimikas S;Karwatowska-Prokopczuk E;Gouni-Berthold I;Tardif Jc

  765
  Citations

• Lipoprotein(a), PCSK9 Inhibition, and Cardiovascular Risk.

  Michelle L. O’Donoghue;Sergio Fazio;Robert P. Giugliano;Erik S.G. Stroes

  754
  Citations

• Homozigot ailevi hiperkolesterolemi: klinisyenlerin tanıyı ve klinik yönetimi geliştirmelerine yönelik yeni anlayışlar ve rehberlik. Avrupa Ateroskleroz Derneği’nin Ailevi Hiperkolesterolemi Üzerine Uzlaşı Paneli yazılı görüşü

  Marina Cuchel;Eric Bruckert;Henry N. Ginsberg;Frederick J. Raal

  705
  Citations

• Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials

  Nicholas J Viney;Julian C van Capelleveen;Richard S Geary;Shuting Xia

  699
  Citations

• Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance : The GAUSS-2 Randomized, Placebo-Controlled Phase 3 Clinical Trial of Evolocumab

  Erik Stroes;David Colquhoun;David Sullivan;Fernando Civeira

  687
  Citations

• Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo

  Max Nieuwdorp;Timon W. van Haeften;Mirella C.L.G. Gouverneur;Hans L. Mooij

  652
  Citations

• The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

  Robert A. Hegele;Henry N. Ginsberg;M. John Chapman;Børge G. Nordestgaard

  614
  Citations

• Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.

  Rakesh S. Birjmohun;Barbara A. Hutten;John J.P. Kastelein;Erik S.G. Stroes

  597
  Citations

• Vascular function in the forearm of hypercholesterolaemic patients off and on lipid-lowering medication.

  E.S.G. Stroes;H.A. Koomans;T.J. Rabelink;T.W.A. de Bruin

  595
  Citations

• Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity

  Anne Vrieze;Carolien Out;Susana Fuentes;Lisanne Jonker

  589
  Citations